Form 4: Jupiter Neurosciences Director Reports Stock Transaction
Insider Transaction (Form 4)
Julie B. Kampf, a Director of Jupiter Neurosciences, Inc., reported multiple transactions in common stock on June 2, 2025.
Summary
- Option exercise/conversion: acquired 82,875 Common Stock on June 2, 2025; holds 82,875 after (Direct).
- Option exercise/conversion: disposed of 82,875 Restricted Stock Units on June 2, 2025 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Julie B. Kampf — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2025-06-02 | Option exercise/conversion | Common Stock | 82,875 | — | — | 82,875 |
| 2025-06-02 | Option exercise/conversion | Restricted Stock Units | 82,875 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2025-06-02 | Option exercise/conversion (82,875 shares) |
| 2025-06-02 | Option exercise/conversion (82,875 shares) |
Keywords
insider transaction, Form 4, JUNS, JUPITER NEUROSCIENCES, INC., neutral, Julie B. Kampf
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.